TY - JOUR
T1 - “It changes everything”
T2 - Understanding how people experience the impact of living with a lower-grade glioma
AU - on behalf of the Ways Ahead study team
AU - Rimmer, Ben
AU - Balla, Michelle
AU - Dutton, Lizzie
AU - Williams, Sophie
AU - Lewis, Joanne
AU - Gallagher, Pamela
AU - Finch, Tracy
AU - Burns, Richéal
AU - Araújo-Soares, Vera
AU - Menger, Fiona
AU - Sharp, Linda
N1 - Publisher Copyright:
© 2024 Oxford University Press. All rights reserved.
PY - 2024/6/1
Y1 - 2024/6/1
N2 - Background. Quantitative studies show people living with a lower-grade glioma (LGG) often report low health-related quality of life. However, it is unclear how this impact is experienced; resulting supportive care needs are also poorly understood. We explored how people experience the impact of living long-term with an LGG, to help identify potential supportive care needs. Methods. We conducted semi-structured interviews with a diverse group of people with LGG (n = 28) across the United Kingdom, who had completed primary treatment (male n = 16, female n = 12, mean age 54.6 years, mean time since diagnosis 8.7 years). Interviews were transcribed and inductive thematic analysis was conducted. Results. Four themes relating to the impact experiences of people with LGG were generated: “Emotional response to the diagnosis,” “Living with the ‘What ifs’,” “Changing relationships,” and “Faltering independence.” These reflect participants’ experiences with symptoms (eg, fatigue, seizures) and impairments (eg, motor dysfunction, cognitive deficits), and how these, in turn, drive impacts on daily living (including on work, relationships, social activities, and transport). Participants spoke about their experiences with profound emotion throughout. Conclusions. People with LGG can experience wide-ranging everyday impacts and may have extensive supportive care needs. This study highlights how this impact is experienced and what it means to people with LGG. Best practice suggestions for conducting comprehensive needs assessments tailored to those with LGG, and the development of personalized plans to meet those needs, would be a critical step to ensure that people with LGG are best supported in living with their condition.
AB - Background. Quantitative studies show people living with a lower-grade glioma (LGG) often report low health-related quality of life. However, it is unclear how this impact is experienced; resulting supportive care needs are also poorly understood. We explored how people experience the impact of living long-term with an LGG, to help identify potential supportive care needs. Methods. We conducted semi-structured interviews with a diverse group of people with LGG (n = 28) across the United Kingdom, who had completed primary treatment (male n = 16, female n = 12, mean age 54.6 years, mean time since diagnosis 8.7 years). Interviews were transcribed and inductive thematic analysis was conducted. Results. Four themes relating to the impact experiences of people with LGG were generated: “Emotional response to the diagnosis,” “Living with the ‘What ifs’,” “Changing relationships,” and “Faltering independence.” These reflect participants’ experiences with symptoms (eg, fatigue, seizures) and impairments (eg, motor dysfunction, cognitive deficits), and how these, in turn, drive impacts on daily living (including on work, relationships, social activities, and transport). Participants spoke about their experiences with profound emotion throughout. Conclusions. People with LGG can experience wide-ranging everyday impacts and may have extensive supportive care needs. This study highlights how this impact is experienced and what it means to people with LGG. Best practice suggestions for conducting comprehensive needs assessments tailored to those with LGG, and the development of personalized plans to meet those needs, would be a critical step to ensure that people with LGG are best supported in living with their condition.
KW - lower-grade glioma
KW - qualitative
KW - quality of life
KW - supportive care needs
UR - http://www.scopus.com/inward/record.url?scp=85188237606&partnerID=8YFLogxK
U2 - 10.1093/nop/npae006
DO - 10.1093/nop/npae006
M3 - Article
AN - SCOPUS:85188237606
SN - 2054-2577
VL - 11
SP - 255
EP - 265
JO - Neuro-Oncology Practice
JF - Neuro-Oncology Practice
IS - 3
ER -